BACKGROUND: Aberrant epithelial repair is a key event in the airway remodelling which characterises obliterative bronchiolitis (OB) in the transplanted lung. The potential for airway epithelium from lung transplant recipients to undergo epithelial to mesenchymal cell transition (EMT) was assessed in culture and in vivo in lung allograft tissue. METHODS: Change in epithelial and mesenchymal marker expression was assessed after stimulation with transforming growth factor beta(1) (TGF-beta(1)) alone or in combination with tumour necrosis factor alpha (TNFalpha) and compared with untreated controls. The ability of cells to deposit extracellular matrix, secrete matrix metalloproteinases (MMPs) and invade collagen was investigated. Immunolocalisation of epithelial and mesenchymal markers was compared in airway tissue from stable recipients and those with OB. RESULTS: Untreated cells maintained epithelial morphology and phenotype. TGF-beta(1) reduced expression of epithelial markers, increased expression of vimentin and fibronectin, promoted collagen I and fibronectin deposition and increased MMP-9 production. Co-treatment with TNFalpha dramatically accentuated phenotypic and some functional features of EMT. Airway epithelial biopsies from recipients with OB demonstrated significantly increased staining for mesenchymal markers and significantly reduced E-cadherin staining compared with stable recipients. CONCLUSIONS: These observations demonstrate the ability of human airway epithelium to undergo EMT and suggest this phenomenon may be a potential link between inflammatory injury and TGF-beta(1)-driven airway remodelling in the development of OB.
BACKGROUND: Aberrant epithelial repair is a key event in the airway remodelling which characterises obliterative bronchiolitis (OB) in the transplanted lung. The potential for airway epithelium from lung transplant recipients to undergo epithelial to mesenchymal cell transition (EMT) was assessed in culture and in vivo in lung allograft tissue. METHODS: Change in epithelial and mesenchymal marker expression was assessed after stimulation with transforming growth factor beta(1) (TGF-beta(1)) alone or in combination with tumour necrosis factor alpha (TNFalpha) and compared with untreated controls. The ability of cells to deposit extracellular matrix, secrete matrix metalloproteinases (MMPs) and invade collagen was investigated. Immunolocalisation of epithelial and mesenchymal markers was compared in airway tissue from stable recipients and those with OB. RESULTS: Untreated cells maintained epithelial morphology and phenotype. TGF-beta(1) reduced expression of epithelial markers, increased expression of vimentin and fibronectin, promoted collagen I and fibronectin deposition and increased MMP-9 production. Co-treatment with TNFalpha dramatically accentuated phenotypic and some functional features of EMT. Airway epithelial biopsies from recipients with OB demonstrated significantly increased staining for mesenchymal markers and significantly reduced E-cadherin staining compared with stable recipients. CONCLUSIONS: These observations demonstrate the ability of human airway epithelium to undergo EMT and suggest this phenomenon may be a potential link between inflammatory injury and TGF-beta(1)-driven airway remodelling in the development of OB.
Authors: Christine V Kinnier; Tereza Martinu; Kymberly M Gowdy; Julia L Nugent; Francine L Kelly; Scott M Palmer Journal: Transpl Immunol Date: 2010-11-09 Impact factor: 1.708
Authors: Guoping Li; John Fox; Zhigang Liu; Jun Liu; George F Gao; Yang Jin; Hongwei Gao; Min Wu Journal: J Immunol Date: 2013-10-14 Impact factor: 5.422
Authors: Vibha N Lama; John A Belperio; Jason D Christie; Souheil El-Chemaly; Michael C Fishbein; Andrew E Gelman; Wayne W Hancock; Shaf Keshavjee; Daniel Kreisel; Victor E Laubach; Mark R Looney; John F McDyer; Thalachallour Mohanakumar; Rebecca A Shilling; Angela Panoskaltsis-Mortari; David S Wilkes; Jerry P Eu; Mark R Nicolls Journal: JCI Insight Date: 2017-05-04
Authors: Nuria E Cabrera-Benítez; Matteo Parotto; Martin Post; Bing Han; Peter M Spieth; Wei-Erh Cheng; Francisco Valladares; Jesús Villar; Mingayo Liu; Masaaki Sato; Haibo Zhang; Arthur S Slutsky Journal: Crit Care Med Date: 2012-02 Impact factor: 7.598
Authors: Jason M Gauthier; Daniel Ruiz-Pérez; Wenjun Li; Ramsey R Hachem; Varun Puri; Andrew E Gelman; Daniel Kreisel Journal: Transplantation Date: 2018-09 Impact factor: 4.939
Authors: Vandy P Stober; Christopher Szczesniak; Quiana Childress; Rebecca L Heise; Carl Bortner; John W Hollingsworth; Isabel P Neuringer; Scott M Palmer; Stavros Garantziotis Journal: Am J Physiol Lung Cell Mol Physiol Date: 2014-04-18 Impact factor: 5.464